Cross-sectional and longitudinal evaluation of liver volume and total liver fat burden in adults with nonalcoholic steatohepatitis

Abdominal Imaging

Volumn 40, Issue 1, 2015, Pages 26-37

  Tang, An ^a,b   Chen, Joshua ^a   Le, Thuy Anh ^c   Changchien, Christopher ^a   Hamilton, Gavin ^a   Middleton, Michael S ^a   Loomba, Rohit ^c   Sirlin, Claude B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biological markers; Fatty liver; Liver; Magnetic resonance imaging; Organ size

Indexed keywords

BIOLOGICAL MARKER; COLESEVELAM; ALLYLAMINE; HYPOCHOLESTEROLEMIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER BIOPSY; LIVER WEIGHT; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ADIPOSE TISSUE; AGED; ANALOGS AND DERIVATIVES; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; ORGAN SIZE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADIPOSE TISSUE; AGED; ALLYLAMINE; ANTICHOLESTEREMIC AGENTS; COLESEVELAM HYDROCHLORIDE; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; ORGAN SIZE;

EID: 84958059229     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-014-0175-0     Document Type: Article

References (55)

1. McCullough AJ (2011) Epidemiology of the metabolic syndrome in the USA. J Dig Dis 12(5):333–340. doi:10.1111/j.1751-2980.2010.00469.x
2. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome—a new worldwide definition. Lancet 366(9491):1059–1062
3. Targher G, Bertolini L, Padovani R, et al. (2006) Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 29(6):1325–1330. doi:10.2337/dc06-0135
4. Targher G, Bertolini L, Poli F, et al. (2005) Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54(12):3541–3546
5. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363(14):1341–1350. doi:10.1056/NEJMra0912063
6. Rubinstein E, Lavine JE, Schwimmer JB (2008) Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Semin Liver Dis 28(4):380–385. doi:10.1055/s-0028-1091982
7. Loomba R, Abraham M, Unalp A, et al. (2012) Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 56(3):943–951. doi:10.1002/hep.25772
8. Promrat K, Kleiner DE, Niemeier HM, et al. (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51(1):121–129. doi:10.1002/hep.23276
9. Vilar Gomez E, Rodriguez De Miranda A, Gra Oramas B, et al. (2009) Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther 30(10):999–1009. doi:10.1111/j.1365-2036.2009.04122.x
10. Belfort R, Harrison SA, Brown K, et al. (2006) A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 355(22):2297–2307. doi:10.1056/NEJMoa060326
11. Sanyal AJ, Chalasani N, Kowdley KV, et al. (2010) Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362(18):1675–1685. doi:10.1056/NEJMoa0907929
12. Lavine JE, Schwimmer JB, Van Natta ML, et al. (2011) Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 305(16):1659–1668. doi:10.1001/jama.2011.520
13. Le TA, Chen J, Changchien C, et al. (2012) Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 56(3):922–932. doi:10.1002/hep.25731
14. Loomba R, Lutchman G, Kleiner DE, et al. (2009) Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther 29(2):172–182. doi:10.1111/j.1365-2036.2008.03869.x
15. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94(9):2467–2474
16. Kleiner DE, Brunt EM, Van Natta M, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313–1321
17. Marsman H, Matsushita T, Dierkhising R, et al. (2004) Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol 35(4):430–435
18. Franzen LE, Ekstedt M, Kechagias S, Bodin L (2005) Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting. Mod Pathol 18(7):912–916. doi:10.1038/modpathol.3800370
19. Hines CD, Yu H, Shimakawa A, et al. (2010) Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology 254(1):119–128. doi:10.1148/radiol.09090131
20. Longo R, Pollesello P, Ricci C, et al. (1995) Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5(3):281–285
21. Szczepaniak LS, Babcock EE, Schick F, et al. (1999) Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol Cell Physiol 276(5 Pt 1):E977–E989
22. Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34(4):729–749. doi:10.1002/jmri.22580
23. Yokoo T, Bydder M, Hamilton G, et al. (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251(1):67–76. doi:10.1148/radiol.2511080666
24. Yokoo T, Shiehmorteza M, Hamilton G, et al. (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258(3):749–759. doi:10.1148/radiol.10100659
25. Meisamy S, Hines CD, Hamilton G, et al. (2011) Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 258(3):767–775. doi:10.1148/radiol.10100708
26. Guaraldi G, Besutti G, Stentarelli C, et al. (2012) Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. Antivir Ther 17(6):965–971. doi:10.3851/IMP2228
27. Bydder M, Yokoo T, Hamilton G, et al. (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26(3):347–359. doi:10.1016/j.mri.2007.08.012
28. Guiu B, Petit JM, Loffroy R, et al. (2009) Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 250(1):95–102
29. Reeder SB, Robson PM, Yu H, et al. (2009) Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 29(6):1332–1339. doi:10.1002/jmri.21751
30. Tang A, Tan J, Sun M, et al. (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267(2):422–431. doi:10.1148/radiol.12120896
31. Idilman IS, Aniktar H, Idilman R, et al. (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267(3):767–775. doi:10.1148/radiol.13121360
32. Park SH, Kim PN, Kim KW, et al. (2006) Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 239(1):105–112. doi:10.1148/radiol.2391050361
33. Bora A, Alptekin C, Yavuz A, et al. (2014) Assessment of liver volume with computed tomography and comparison of findings with ultrasonography. Abdom Imaging. doi:10.1007/s00261-014-0146-5
34. Strauss S, Gavish E, Gottlieb P, Katsnelson L (2007) Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 189(6):W320–W323. doi:10.2214/AJR.07.2123
35. Lu ZF, Zagzebski JA, Lee FT (1999) Ultrasound backscatter and attenuation in human liver with diffuse disease. Ultrasound Med Biol 25(7):1047–1054
36. Webb M, Yeshua H, Zelber-Sagi S, et al. (2009) Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol 192(4):909–914. doi:10.2214/AJR.07.4016
37. van Werven JR, Marsman HA, Nederveen AJ, et al. (2010) Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 256(1):159–168. doi:10.1148/radiol.10091790
38. Nomura F, Ohnishi K, Ochiai T, Okuda K (1987) Obesity-related nonalcoholic fatty liver: CT features and follow-up studies after low-calorie diet. Radiology 162(3):845–847
39. Chen TY, Chen CL, Tsang LL, et al. (2008) Correlation between hepatic steatosis, hepatic volume, and spleen volume in live liver donors. Transplant Proc 40(8):2481–2483. doi:10.1016/j.transproceed.2008.08.045
40. Lewis MC, Phillips ML, Slavotinek JP, et al. (2006) Change in liver size and fat content after treatment with Optifast very low calorie diet. Obes Surg 16(6):697–701. doi:10.1381/096089206777346682
41. Hussain HK, Chenevert TL, Londy FJ, et al. (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display: early experience. Radiology 237(3):1048–1055
42. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB (2007) Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 58(2):354–364
43. Yu H, McKenzie CA, Shimakawa A, et al. (2007) Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 26(4):1153–1161. doi:10.1002/jmri.21090
44. Hamilton G, Yokoo T, Bydder M, et al. (2011) In vivo characterization of the liver fat (1)H MR spectrum. NMR Biomed 24(7):784–790. doi:10.1002/nbm.1622
45. Szczepaniak LS, Nurenberg P, Leonard D, et al. (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Cell Physiol 288(2):E462–E468
46. Hansen KH, Schroeder ME, Hamilton G, Sirlin CB, Bydder M (2012) Robustness of fat quantification using chemical shift imaging. Magn Reson Imaging 30(2):151–157. doi:10.1016/j.mri.2011.09.011
47. Kang GH, Cruite I, Shiehmorteza M, et al. (2011) Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging 34(4):928–934. doi:10.1002/jmri.22701
48. Hines CD, Frydrychowicz A, Hamilton G, et al. (2011) T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 33(4):873–881. doi:10.1002/jmri.22514
49. Limanond P, Raman SS, Lassman C, et al. (2004) Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230(1):276–280. doi:10.1148/radiol.2301021176
50. d’Assignies G, Kauffmann C, Boulanger Y, et al. (2011) Simultaneous assessment of liver volume and whole liver fat content: a step towards one-stop shop preoperative MRI protocol. Eur Radiol 21(2):301–309. doi:10.1007/s00330-010-1941-1
51. Reeder SB, Hines CD, Yu H, McKenzie CA, Brittain JH (2009) On The definition of fat-fraction for in vivo fat quantification with magnetic resonance imaging [abstr.]. In: Proceedings of the seventeenth meeting of the international society for magnetic resonance in medicine, Berkeley: International Society for Magnetic Resonance in Medicine
52. Reeder SB, Hines CD, Yu H, McKenzie CA, Brittain JH (2011) Relationship between proton-density fat-fraction and true fat concentration for in vivo fat quantification with magnetic resonance imaging [abstr.]. In: Proceedings of the Nineteenth meeting of the international society for magnetic resonance in medicine, Berkeley, CA: International Society for Magnetic Resonance in Medicine
53. Hu HH, Li Y, Nagy TR, Goran MI, Nayak KS (2012) Quantification of absolute fat mass: a validation study between chemical-shift mri and chemical analysis. In: Proceedings of the twentieth meeting of the international society for magnetic resonance in medicine, Berkeley, CA: International Society for Magnetic Resonance in Medicine
54. Kiki I, Altunkaynak BZ, Altunkaynak ME, et al. (2007) Effect of high fat diet on the volume of liver and quantitative feature of Kupffer cells in the female rat: a stereological and ultrastructural study. Obes Surg 17(10):1381–1388. doi:10.1007/s11695-007-9219-7
55. Permutt Z, Le TA, Peterson MR, et al. (2012) Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease: MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 36(1):22–29. doi:10.1111/j.1365-2036.2012.05121.x